系统性红斑狼疮、糖尿病与医疗补助人群中CVD风险的比较
本研究基于美国Medicaid 2007-2010年数据,按年龄和性别1:2:4匹配SLE、DM和一般人群,比较非致死性心血管事件风险。SLE患者的非致死性CVD风险高于DM患者(HR 1.27,95%CI 1.15-1.40),且18-39岁年龄组风险最高(HR 2.22,95%CI 1.81-2.71);SLE患者风险是一般人群的2.67倍(95%CI 2.38-2.99)。
要点
- SLE患者非致死性CVD风险高于匹配的DM患者(HR 1.27)。
- 18-39岁SLE患者相对风险最高(HR 2.22)。
- SLE患者CVD风险为一般人群2.67倍。
核心结论
- SLE患者非致死性CVD风险较年龄性别匹配的DM患者高27%,较Medicaid一般人群高2倍以上。
- 18-39岁年龄组相对风险最高。
研究设计与样本
- 队列研究,使用Medicaid Analytic eXtract 2007-2010年数据。
- 按年龄和性别1:2:4匹配SLE、DM和一般人群成人,共纳入40,212例SLE、80,424例DM和160,848例一般人群。
主要发现
- 非致死性CVD发病率(每1000人年):SLE 8.99,DM 7.07,一般人群2.36。
- SLE vs DM的HR为1.27(95%CI 1.15-1.40),18-39岁HR为2.22(95%CI 1.81-2.71)。
- SLE vs 一般人群的HR为2.67(95%CI 2.38-2.99)。
临床怎么用
- SLE患者应积极评估可改变的心血管危险因素。
- 需研究识别预防策略以降低SLE患者CVD风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular disease (CVD) risk is elevated in patients with systemic lupus erythematosus (SLE) and diabetes mellitus (DM), but whether risk of CVD in patients with SLE is as high as in those with DM is unknown. The present study was undertaken to compare CVD risks between patients with SLE and DM and general population US Medicaid recipients. METHODS: In a cohort study, we identified age- and sex-matched adults (1:2:4) with SLE or DM and those from the general population using Medicaid Analytic eXtract, 2007-2010. We collected data on baseline sociodemographic factors, comorbidities, and medications. We used Cox regression models to calculate hazard ratios (HRs) of hospitalized nonfatal CVD events (combined myocardial infarction [MI] and stroke) and MI and stroke separately, accounting for competing risk of death and adjusting for covariates. We compared risks in age-stratified models. RESULTS: We identified 40,212 SLE patients, 80,424 DM patients, and 160,848 general population patients; 92.5% were female, and the mean ± SD age was 40.3 ± 12.1 years. Nonfatal CVD incidence rate per 1,000 person-years was 8.99 for patients with SLE, 7.07 for those with DM, and 2.36 for the general population. Nonfatal CVD risk was higher in SLE compared to DM (HR 1.27 [95% confidence interval (95% CI) 1.15-1.40]), driven by excess risk at ages 18-39 years (HR 2.22 [95% CI 1.81-2.71]). Patients with SLE had higher risk of CVD compared to the general population (HR 2.67 [95% CI 2.38-2.99]). CONCLUSION: SLE patients had a 27% higher risk of nonfatal CVD events compared to age- and sex-matched patients with DM and more than twice the risk of the Medicaid general population. The highest relative risk occurred at ages 18-39 years. These high risks merit aggressive evaluation for modifiable factors and research to identify prevention strategies.
引用
- Barbhaiya M, Feldman CH, Chen SK, et al. Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients. Arthritis Care Res (Hoboken). 2020. PMID: 32475049. doi:10.1002/acr.24328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。